NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,253 | +1.1% | 3,409 | +0.2% | 0.16% | +10.3% |
| Q2 2023 | $343,409 | +9.7% | 3,403 | -0.0% | 0.15% | +0.7% |
| Q1 2023 | $313,179 | +0.9% | 3,404 | -0.5% | 0.14% | -2.7% |
| Q4 2022 | $310,455 | +19.4% | 3,422 | -0.0% | 0.15% | +4.9% |
| Q3 2022 | $260,000 | -13.0% | 3,423 | -3.3% | 0.14% | -10.7% |
| Q2 2022 | $299,000 | -4.5% | 3,540 | -0.7% | 0.16% | +22.3% |
| Q1 2022 | $313,000 | +3.3% | 3,565 | +3.0% | 0.13% | +6.6% |
| Q4 2021 | $303,000 | +7.4% | 3,461 | +0.4% | 0.12% | +0.8% |
| Q3 2021 | $282,000 | -9.9% | 3,446 | +0.6% | 0.12% | +65.8% |
| Q2 2021 | $313,000 | -49.0% | 3,427 | -52.3% | 0.07% | -44.3% |
| Q1 2021 | $614,000 | -8.6% | 7,192 | +1.2% | 0.13% | -22.0% |
| Q4 2020 | $672,000 | -5.1% | 7,108 | -12.7% | 0.17% | -13.0% |
| Q3 2020 | $708,000 | -4.3% | 8,144 | -3.8% | 0.19% | -6.8% |
| Q2 2020 | $740,000 | -2.0% | 8,466 | -7.5% | 0.21% | -5.0% |
| Q1 2020 | $755,000 | -16.0% | 9,157 | -3.6% | 0.22% | -6.0% |
| Q4 2019 | $899,000 | – | 9,497 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |